Sotera Health Co
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.0B | $1.0B | $931.5M |
| Gross profit | $645.5M | $602.3M | $577.2M | $557.0M | $518.7M |
| Operating income | — | $297.6M | $276.7M | $248.3M | $256.7M |
| Operating expenses | — | $304.7M | $300.5M | $308.7M | $261.9M |
| Cost of revenue | $518.1M | $498.1M | $472.1M | $446.7M | $412.8M |
| Cash from operations | $287.2M | $224.2M | -$147.7M | $278.0M | $281.5M |
| Capital expenditure | $138.0M | $179.1M | $215.0M | $182.4M | $102.2M |
| Free cash flow | $149.2M | $45.1M | -$362.7M | $95.6M | $179.4M |
| Share repurchases | — | — | — | $0 | $0 |
| Impairments | — | — | — | — | $0 |
| Total assets | $3.3B | $3.1B | $3.1B | $3.1B | $2.8B |
| Total liabilities | $2.7B | $2.7B | $2.7B | $2.8B | $2.2B |
| Total debt | $2.2B | $2.3B | $2.3B | $2.0B | $1.8B |
Shares outstanding 285.2M · Free float 84.6%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.